BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32831036)

  • 21. Vessel invasion as a predictive factor for recurrence after surgery in stage I lung adenocarcinoma.
    Muranishi Y; Tanaka N; Kono T; Miyahara R
    Respir Investig; 2022 Mar; 60(2):227-233. PubMed ID: 34933825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative biopsy and tumor recurrence of stage I adenocarcinoma of the lung.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Chen HS; Wu MH; Chou TY; Hsu WH; Shih CC; Huang BS
    Surg Today; 2020 Jul; 50(7):673-684. PubMed ID: 31873771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can Quantitative Volumetric Analysis Predict Tumor Recurrence in the Patients with Mucinous Adenocarcinoma of the Lung After Surgical Resection?
    Lim JK; Shin KM; Lee HJ; Lee H; Hahm MH; Lee J; Kim CH; Cha SI; Jeong JY; Park TI
    Acad Radiol; 2019 May; 26(5):e21-e31. PubMed ID: 30064921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of Spread Through Air Spaces in Resected Pathological Stage I Lung Adenocarcinoma.
    Toyokawa G; Yamada Y; Tagawa T; Kozuma Y; Matsubara T; Haratake N; Takamori S; Akamine T; Oda Y; Maehara Y
    Ann Thorac Surg; 2018 Jun; 105(6):1655-1663. PubMed ID: 29453963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk of recurrence in resected EGFR-positive pN0M0 invasive lung adenocarcinoma.
    Ito M; Miyata Y; Kushitani K; Yoshiya T; Kai Y; Tsutani Y; Mimura T; Konishi K; Takeshima Y; Okada M
    Thorac Cancer; 2018 Dec; 9(12):1594-1602. PubMed ID: 30298562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.
    Khorrami M; Bera K; Leo P; Vaidya P; Patil P; Thawani R; Velu P; Rajiah P; Alilou M; Choi H; Feldman MD; Gilkeson RC; Linden P; Fu P; Pass H; Velcheti V; Madabhushi A
    Lung Cancer; 2020 Apr; 142():90-97. PubMed ID: 32120229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size.
    Chen C; Fu S; Ni Q; Yiyang W; Pan X; Jing J; Zhao H; Rui W
    Med Sci Monit; 2019 Nov; 25():9003-9011. PubMed ID: 31772147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
    Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
    Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
    Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes and predictive factors for pathological node-positive in radiographically pure-solid, small-sized lung adenocarcinoma.
    Kayata H; Isaka M; Terada Y; Mizuno K; Yasuura Y; Kojima H; Ohde Y
    Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):544-550. PubMed ID: 30627979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic stratification model for patients with stage I non-small cell lung cancer adenocarcinoma treated with surgical resection without adjuvant therapies using metabolic features measured on F-18 FDG PET and postoperative pathologic factors.
    Kang YK; Song YS; Cho S; Jheon S; Lee WW; Kim K; Kim SE
    Lung Cancer; 2018 May; 119():1-6. PubMed ID: 29656743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery.
    Isaka T; Nakayama H; Ito H; Yokose T; Yamada K; Masuda M
    BMC Cancer; 2018 Oct; 18(1):959. PubMed ID: 30290774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
    Sekihara K; Hishida T; Yoshida J; Oki T; Omori T; Katsumata S; Ueda T; Miyoshi T; Goto M; Nakasone S; Ichikawa T; Matsuzawa R; Aokage K; Goto K; Tsuboi M
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):522-528. PubMed ID: 28482033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma.
    Uehara H; Tsutani Y; Okumura S; Nakayama H; Adachi S; Yoshimura M; Miyata Y; Okada M
    Ann Thorac Surg; 2013 Dec; 96(6):1958-65. PubMed ID: 24021765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
    Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
    Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung adenocarcinoma with intraoperatively diagnosed pleural seeding: Is main tumor resection beneficial for prognosis?
    Li C; Kuo SW; Hsu HH; Lin MW; Chen JS
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1238-1249.e1. PubMed ID: 29254636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications.
    Ito M; Miyata Y; Kushitani K; Yoshiya T; Mimae T; Ibuki Y; Misumi K; Takeshima Y; Okada M
    Lung Cancer; 2014 Aug; 85(2):270-5. PubMed ID: 24976332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The progression of non-small cell lung cancer from diagnosis to surgery.
    McPherson I; Bradley NA; Govindraj R; Kennedy ED; Kirk AJB; Asif M
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1882-1887. PubMed ID: 32847696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Resection Margin Distance and Invasive Component Size on Recurrence After Sublobar Resection in Patients With Small (≤2 Cm) Lung Adenocarcinoma.
    Moon Y; Park JK; Lee KY
    World J Surg; 2020 Mar; 44(3):990-997. PubMed ID: 31712844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.